Why do I have tachycardia after COVID-19 (Coronavirus disease 2019) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

You likely have tachycardia after COVID-19 due to post-COVID syndrome or Long COVID, which can cause autonomic nervous system dysfunction, leading to inappropriate sinus tachycardia or postural orthostatic tachycardia syndrome (POTS) 1.

Key Considerations

  • COVID-19 can trigger inflammation affecting the heart and nervous system, disrupting normal heart rate regulation 1.
  • Long-term cardiovascular sequelae of COVID-19 may include chest pain, palpitations, inappropriate sinus tachycardia, postural orthostatic tachycardia syndrome, atrial arrhythmia, cardiomyopathy, and thromboembolism 1.
  • A significant proportion of patients may experience long-term complications of SARS-CoV-2 infection 4 weeks from the index infection, sometimes called post-acute COVID-19 syndrome 1.

Recommended Evaluation and Management

  • Consult a healthcare provider for proper evaluation, as they may recommend a beta-blocker like metoprolol (starting at 25mg twice daily) or ivabradine (5mg twice daily) to manage symptoms 1.
  • Lifestyle modifications including gradual exercise reconditioning, increased fluid intake (2-3 liters daily), increased salt intake (unless contraindicated), and compression stockings may be suggested 1.
  • Laboratory tests to check for anemia, thyroid dysfunction, or electrolyte abnormalities would be important to rule out other causes 1.

Important Notes

  • COVID-19 can cause multi-organ damage, including cardiac impairment, which can lead to arrhythmias and other cardiovascular complications 1.
  • The risk for occurrence of thromboembolic complications in the postacute COVID-19 phase is possibly associated with the duration and severity of hyperinflammatory state 1.
  • Specialized evaluation by a cardiologist or autonomic specialist may be beneficial for targeted treatment, especially after persistent symptoms 1.

From the Research

Tachycardia after COVID-19 Infection

  • Tachycardia, particularly sinus tachycardia, is a common electrocardiographic manifestation of COVID-19 2.
  • The ECG abnormalities in COVID-19 may be due to various factors such as cytokine storm, hypoxic injury, electrolyte abnormalities, plaque rupture, coronary spasm, microthrombi, or direct endothelial or myocardial injury 2.
  • Studies have shown that COVID-19 can cause cardiovascular damage, including cardiac injury and arrhythmias, which can lead to tachycardia 3, 4.

Prevalence of Tachycardia after COVID-19

  • One study found that only 5.5% of patients presented with a heart rate > 100 bpm at discharge, suggesting that high heart rate at discharge is not a frequent consequence of COVID-19 3.
  • However, when high heart rate does occur at discharge, it seems to be strongly related to a severe course of the disease 3.

Diagnostic and Prognostic Values of ECG

  • Electrocardiography (ECG) can be a valuable diagnostic and prognostic tool for cardiac evaluation of patients with COVID-19 5.
  • ECG findings such as ST-segment changes, T wave inversions, QT prolongation, and atrial fibrillation can be early indicators of cardiac involvement of COVID-19 and are associated with worse outcomes 5.
  • Echocardiography can also be used to assess cardiovascular disease in patients with COVID-19, providing information on cardiac structure and function 6, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Electrocardiographic manifestations of COVID-19.

The American journal of emergency medicine, 2021

Research

Evaluation of cardiac injury with biomarkers and echocardiography after COVID-19 infection.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2022

Research

Echocardiographic Manifestations in COVID-19: A Review.

Heart, lung & circulation, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.